|
Index of reports
> Cases with Dysphagia ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trileptal (Oxcarbazepine) where reactions include dysphagia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Trileptal side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient: female
Reactions: Eye Discharge, Mouth Ulceration, Petechiae, Pyrexia, Oropharyngeal Pain, Transaminases Increased, Erythema, LIP Erosion, Dermatitis, Liver Function Test Abnormal, Skin Lesion, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Cough, Blister, Swelling Face, Dysphagia, Rhinitis, Vaginal Discharge, Rash, Respiratory Distress, Eye Pain, Alopecia, Dysuria, Eye Swelling, Rash Maculo-Papular, Vaginal Lesion
Drug(s) suspected as cause:
Trileptal
Other drugs received by patient: Nafcillin; Prednisolone; Propofol; Precedex; Benadryl
Possible Trileptal side effects in female
Reported by a lawyer from United States on 2012-08-14
Patient: female, weighing 56.2 kg (123.7 pounds)
Reactions: Abdominal Pain, Pruritus, Vulval Ulceration, Urticaria, Pyrexia, Headache, Oral Candidiasis, Lymph Node Palpable, Hypoxia, Sputum Purulent, Proctalgia, Blister, Blood Gases Abnormal, Dysphagia, Stomatitis, Encephalomalacia, Coronary Artery Disease, Toxic Epidermal Necrolysis, Vaginal Discharge, Periorbital Oedema, Cachexia, Colonoscopy Abnormal, Acute Sinusitis, Rash Erythematous, Insomnia, Aspartate Aminotransferase Increased, Dehydration, Confusional State, Skin Exfoliation, Mouth Ulceration, Nuclear Magnetic Resonance Imaging Brain Abnormal, Hepatitis, Constipation, Death, Blood Calcium Decreased, Haematocrit Decreased, Chest Pain, Blood Sodium Decreased, Blood Glucose Increased, Vomiting, Blood Alkaline Phosphatase, Nausea, Alanine Aminotransferase Increased, Blood Potassium Increased, Facial Pain, Mucosal Inflammation, Haemoglobin Decreased, Oral Pain, Neoplasm Malignant, Respiratory Failure, Asthenia, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Trileptal
Indication: Convulsion
Start date: 2003-01-29
End date: 2003-01-31
Dilantin
Indication: Convulsion
Start date: 2002-12-01
Other drugs received by patient: Ceftriaxone; Acyclovir; Triamcinolone; Nystatin; Gyne-Lotrimin; Pepcid; Fluconazole; Docusate; Neurontin
Possible Trileptal side effects in male
Reported by a consumer/non-health professional from Mexico on 2012-08-10
Patient: male
Reactions: Speech Disorder, Dysphagia, Brain Oedema, Paralysis
Drug(s) suspected as cause:
Trileptal
Possible Trileptal side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-06-25
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Speech Disorder, Dysphagia, Hepatic Calcification, Hypothyroidism, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Trileptal
Other drugs received by patient: Ursacol; Levoid; Lamotrigine; Valproate Sodium
Possible Trileptal side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-05-23
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Speech Disorder, Dysphagia, Hepatic Calcification, Hypothyroidism, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Trileptal
Other drugs received by patient: Lamotrigine; Levoid; Valproate Sodium; Ursacol
Possible Trileptal side effects in 76 year old male
Reported by a physician from Spain on 2012-05-14
Patient: 76 year old male
Reactions: Dysphagia, Aspiration Bronchial, General Physical Health Deterioration, Gait Disturbance, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Keppra
Administration route: Oral
Indication: Epilepsy
Start date: 2010-07-01
End date: 2010-09-24
Trileptal
Administration route: Oral
Indication: Epilepsy
Start date: 2010-07-01
End date: 2010-09-24
Other drugs received by patient: Fluoxetine HCL; Risperdal
Possible Trileptal side effects in 76 year old male
Reported by a physician from Spain on 2012-05-09
Patient: 76 year old male
Reactions: General Physical Condition Abnormal, Dysphagia, Aspiration Bronchial, Drug Interaction, Gait Disturbance, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Trileptal
Other drugs received by patient possibly interacting with the suspect drug:
Keppra
Dosage: 100 mg, bid
Administration route: Oral
Indication: Epilepsy
Start date: 2010-07-01
End date: 2010-09-24
Other drugs received by patient: Fluoxetine; Risperdal
Possible Trileptal side effects in male
Reported by a physician from France on 2011-11-15
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Lymphadenopathy, Blood Creatine Phosphokinase Increased, Respiratory Disorder, High Density Lipoprotein Increased, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Dermatitis Bullous, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Cough, Back Pain, Medical Device Complication, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Renal Colic, Corneal Neovascularisation, Skin Exfoliation, Eye Discharge, Scab, Symblepharon, Nephrolithiasis, Photophobia, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Cataract, Epilepsy, Iris Adhesions, Alopecia, Lacrimation Decreased, Gait Disturbance, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Levetiracetam; Clobazam; Topiramate; Clonazepam
|
